Developing minimally invasive circulatory support systems.
CircuLite is developing minimally invasive circulatory support systems. SYNERGY is a miniature ventricular support system that offers the potential of a new minimally invasive treatment option for patients with chronic heart failure who are not responding to standard medical care. SYNERGY received CE Mark approval in Europe in September 2012. On December, 2, 2013, HeartWare has acquired all of the issued and outstanding equity interests of CircuLite for up to USD 350 million.
- History M&A